First clinical trial with a novel adenovirus vector begins.
Kresge
Jill
J
D016915:AIDS Vaccines; D000256:Adenoviridae / Q000235:genetics*; D017321:Clinical Trials, Phase I as Topic; D005822:Genetic Vectors; D015658:HIV Infections / Q000276:immunology; D006801:Humans
D016915:AIDS Vaccines